beta

ACRS

Aclaris Therapeutics Inc.

Acrs

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

Market Cap: 759 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.aclaristx.com

Shares Outstanding: 30.8 Million

Float: 29.2 Million

Dividend: 0.0 (0.0%)

Beta: 1.451529

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 3.34 Million

Ethical Flags

Animal testing

Longest drawdown: 631 trading days

From: 2017-04-17 To: 2019-10-16

Lowest Point:

Teva hits 19-year low on continued pricing pressure

via: SeekingAlpha at 2019-06-12 06:49:59:000

Teva Pharmaceutical Industries ( TEVA -4.2% ) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the continued erosion of Copaxone sales (down 56% in Q1) and its potential exposure from opioid … read more...

Teva hits 19-year low on continued pricing pressure

via: SeekingAlpha at 2019-06-12 06:49:59:000

Teva Pharmaceutical Industries ( TEVA -4.2% ) slumps on modestly higher volume. Shares are now exchanging hands at the lowest prices in 19 years. The stock continues to fight pricing headwinds, the continued erosion of Copaxone sales (down 56% in Q1) and its potential exposure from opioid … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud